Research analysts at StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO – Get Free Report) in a report issued on Friday. The firm set a “strong-buy” rating on the medical research company’s stock.
Global Cord Blood Price Performance
NYSE:CO opened at $0.83 on Friday. The firm’s fifty day moving average price is $1.00 and its 200 day moving average price is $1.28. Global Cord Blood has a 1-year low of $2.03 and a 1-year high of $5.50. The firm has a market cap of $100.28 million, a price-to-earnings ratio of 1.29 and a beta of 0.16.
Global Cord Blood Company Profile
Read More
- Five stocks we like better than Global Cord Blood
- What Are Dividend Challengers?
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- 3 Best Fintech Stocks for a Portfolio Boost
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.